Regulatory & Legal

Nicox's novel glaucoma drug NCX 470 receives positive FDA feedback, keeping its 2026 U.S. market submission on track to challenge a $7B industry.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

The self-storage giant affirmed its Q1 dividend, signaling stability to investors, but faces a mixed Wall Street outlook and a new legal challenge.

As state and federal cuts threaten vital services, Bloomington Health Foundation offers critical bridge funding to stabilize local nonprofits on the brink.

With $100M from its new IPO, XFLH Capital joins a resurgent SPAC market. But can its Asia-focused strategy overcome a history of investor risk?

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Dr. Bruce Gnade's election to the NAE highlights a career of innovation and his new mission: building the future semiconductor workforce in North Texas.

Facing a massive exodus of players and tax revenue to offshore sites, Finland is dismantling its state monopoly for a regulated online gambling market.

As devastating wildfires become more common, toxic smoke is seeping indoors. Learn about the hidden health risks and the technology that can keep you safe.

California University of Science and Medicine achieves top national accreditation, a major validation of its mission to fix the region's critical doctor shortage.

The offender monitoring firm reversed a $2M loss, posting a $0.5M Q1 profit after focusing on key US states and shedding international assets.

With triple-digit loan volume growth and a landmark AAA rating, Figure Technology Solutions' latest results suggest tokenized assets are finally breaking through.

A new "smart bomb" cancer drug, PB-223, shows complete tumor eradication with minimal toxicity in preclinical studies, setting the stage for a new battle.

A new SEC-registered transfer agent, OpenAgent, launches to bridge blockchain efficiency with institutional compliance, heralding a new era for digital assets.

A new ETF, EXEQ, uses AI to score and invest in corporate leadership, aiming to turn a qualitative trait into a data-driven source of returns.

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.

Las Vegas Sands names Patrick Dumont CEO, signaling a new chapter focused on executing massive multi-billion dollar investments in Macao and Singapore.

With 15 'Best Bank' awards fueled by client feedback and record SBA lending, Huntington Bank demonstrates a winning formula for business banking success.

Formula 1 phenom Ollie Bearman isn't just endorsing IM8 Health; he's investing in it, signaling a major shift in how athletes partner with brands.

Veradigm's new platform aims to merge patient stories with clinical data, but faces a competitive market and lingering questions about data privacy.